Singulair montelukast sodium
|
Merck Raises Sales Forecast on Strong Earnings Report
FDA news (subscription), VA - Forecasts for allergy medicine Singulair (montelukast sodium) and hypertension treatment Cozaar (losartan potassium) were each increased by $100 million to … |
Add to: | Technorati | Digg | del.icio.us | Yahoo | BlinkList | Spurl | reddit | Furl |
